This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NYSE Euronext (NYSE:NYX) today provided the following statement and timeline for the completion of its pending acquisition by IntercontinentalExchange (NYSE: ICE), a leading operator of global markets and clearing houses.
ICE and NYSE Euronext have established a closing date of November 4, 2013 for their previously announced transaction. The November 4, 2013 closing date is predicated upon the receipt by IntercontinentalExchange and NYSE Euronext of remaining European regulatory approvals prior to such date, and may be extended to a later date by further public announcement should any necessary approvals remain outstanding at such date.
ICE and NYSE Euronext have also established an election deadline for shareholders of NYSE Euronext to make merger consideration elections of stock and/or cash consideration of 5:00 p.m., New York City time, on October 31, 2013, with such election deadline being fixed unless extended by ICE through further public announcement.
Shareholders of NYSE Euronext who hold shares through a financial intermediary such as a bank, broker, trust company or other nominee may have an earlier election deadline and should carefully review any instructions received from their bank, broker, trust company or other nominee in order to comply with any earlier deadline. Information regarding merger consideration election mechanics has previously been distributed to shareholders of NYSE Euronext and/or their financial intermediaries located in non-European jurisdictions, and such information will be sent to shareholders of NYSE Euronext and/or their financial intermediaries located in Europe in the coming days. Shareholders of NYSE Euronext with questions regarding the election procedures or materials should contact their financial intermediary, or Georgeson Inc., the information agent for the transaction, at 888-566-8006 (toll free in the United States) or 781-575-2137 (outside the United States).
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets - the New York Stock Exchange, NYSE Euronext, NYSE MKT, NYSE Alternext and NYSE Arca - represent one-third of the world’s equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit:
Please follow us at:
Exchanges BlogFacebookLinkedInTwitterCAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS
This written communication contains “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “may,” “hope,” “will,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” “continue,” “could,” “future” or the negative of those terms or other words of similar meaning. You should carefully read forward-looking statements, including statements that contain these words, because they discuss our future expectations or state other “forward-looking” information. Forward-looking statements are subject to numerous assumptions, risks and uncertainties which change over time. ICE Group, ICE and NYSE Euronext caution readers that any forward-looking statement is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking statement.